Validation of a LC method for the analysis of oxaliplatin in a pharmaceutical formulation using an experimental design

被引:38
作者
Ficarra, R
Calabrò, ML
Cutroneo, P
Tommasini, S
Melardi, S
Semreen, M
Furlanetto, S
Ficarra, P
Altavilla, G
机构
[1] Univ Messina, Dipartimento Farmacochim, I-98168 Messina, Italy
[2] Univ Messina, Dipartimento Patol Umana Oncol Med, Messina, Italy
[3] Univ Florence, Dipartimento Sci Farmaceut, Florence, Italy
[4] Univ Catanzaro Magna Graecia, Dipartimento Sci Farmacobiol, I-88021 Catanzaro, Italy
关键词
oxaliplatin; RP-HPLC; validation; robustness testing; intermediate precision; experimental design;
D O I
10.1016/S0731-7085(02)00151-6
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
A rapid and sensitive RP-HPLC method with UV detection for routine control of oxaliplatin in a pharmaceutical formulation (Eloxatin(R)) was developed. Quantitation was accomplished with the internal standard method. The procedure was validated by linearity (correlation coefficient = 0.999948), accuracy, robustness and intermediate precision. Experimental design was used during validation to calculate method robustness and intermediate precision. For robustness test three factors were considered: percentage v/v of acetonitrile, flow rate and temperatures an increase in the flow rate results in a decrease of the drug found concentration, while the percentage of organic modifier and temperature have no important effect on the response. For intermediate precision measure the considered variables were: analyst, equipment and days. The RSD value (2.27%, n = 24) indicated a good precision of the analytical method. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:1097 / 1103
页数:7
相关论文
共 16 条
[1]   QUANTITATIVE-DETERMINATION OF CISPLATIN IN BODY-FLUIDS BY LIQUID-CHROMATOGRAPHY WITH QUENCHED PHOSPHORESCENCE DETECTION [J].
BAUMANN, RA ;
GOOIJER, C ;
VELTHORST, NH ;
FREI, RW ;
KLEIN, I ;
VANDERVIJGH, WJF .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1987, 5 (02) :165-170
[2]   ANALYSIS OF PLATINUM SPECIES ORIGINATING FROM CIS-DIAMMINEDICHLOROPLATINUM(II) (CISPLATIN) IN HUMAN AND RAT PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH ONLINE INDUCTIVELY COUPLED PLASMA ATOMIC EMISSION SPECTROMETRIC DETECTION [J].
DEWAAL, WAJ ;
MAESSEN, FJMJ ;
KRAAK, JC .
JOURNAL OF CHROMATOGRAPHY, 1987, 407 :253-272
[4]  
Frank I., 1994, Data analysis handbook
[5]  
HOCKMAN KK, 1995, CHEM ENG-NEW YORK, V102, P142
[6]  
ICH, 1996, 3 INT C HARM TECHN R
[7]   HPLC DETERMINATION OF CIS-DIAMMINEDICHLOROPLATINUM(II) IN PLASMA AND URINE WITH UV DETECTION AND COLUMN-SWITCHING [J].
KIZU, R ;
HAYAKAWA, K ;
MIYAZAKI, M .
BIOMEDICAL CHROMATOGRAPHY, 1989, 3 (01) :14-19
[8]  
KIZU R, 1995, CHEM PHARM BULL, V43, P108
[9]  
Lewis G. A., 1999, PHARM EXPT DESIGN
[10]  
Lin DKJ, 1999, J QUAL TECHNOL, V31, P61